bird
human
transmiss
high
pathogen
avian
influenza
viru
hpaiv
pose
signific
risk
trigger
flu
pandem
human
popul
therefor
vaccin
suscept
poultri
hpaiv
outbreak
might
best
remedi
prevent
transmiss
end
suitabl
formul
effect
mass
vaccin
method
translat
field
set
need
develop
previou
studi
chicken
shown
inhal
nonadjuv
dri
powder
influenza
vaccin
formul
normal
breath
result
partial
protect
lethal
influenza
challeng
aim
present
studi
improv
effect
pulmonari
vaccin
increas
vaccin
dose
deposit
lung
use
suitabl
adjuv
two
adjuv
name
bacteriumlik
particl
blp
advax
spray
freez
dri
influenza
vaccin
dri
powder
formul
deliveri
dri
formul
directli
syrinx
reveal
blp
advax
potenti
boost
either
system
mucos
immun
respons
upon
passiv
inhal
dri
influenza
vaccin
formul
optim
setup
blp
advaxblp
adjuv
formul
induc
significantli
higher
system
immun
respons
nonadjuv
formul
remark
vaccin
anim
surviv
lethal
influenza
challeng
also
show
shed
challeng
viru
except
two
six
anim
advax
group
overal
result
indic
passiv
inhal
feasibl
effect
suitabl
mass
vaccin
chicken
adapt
field
set
outbreak
avian
influenza
poultri
major
sourc
infect
human
outbreak
caus
highli
pathogen
strain
avian
influenza
viru
pose
signific
risk
poultryhuman
transmiss
current
remedi
control
outbreak
cull
poultri
safeti
reason
anim
cull
infect
farmyard
also
noninfect
neighbor
farmyard
slaughter
million
poultri
lead
sever
econom
loss
also
rais
ethic
question
incomprehens
within
societi
combat
outbreak
avian
influenza
viru
could
use
rapidli
vaccin
poultri
area
surround
outbreak
ring
fenc
strategi
howev
would
requir
larg
number
poultri
potenti
ten
hundr
million
abl
immun
within
short
time
period
would
requir
vaccin
formul
rout
immun
suitabl
mass
applic
liquid
powder
influenza
vaccin
formul
aerosol
administ
via
respiratori
tract
could
appropri
formul
mass
vaccin
liquid
formul
inactiv
influenza
viru
shown
inadequ
aerosol
vaccin
singl
administr
powder
formul
hand
shown
advantag
liquid
formul
longterm
storag
stabil
long
term
stabil
facilit
stockpil
thu
provid
eas
administr
mass
vaccin
previou
studi
shown
pulmonari
immun
dispers
dri
powder
influenza
vaccin
directli
syrinx
chicken
activ
administr
abl
complet
protect
anim
lethal
viral
challeng
howev
realist
situat
due
extrem
time
pressur
activ
administr
chicken
unsuit
mass
vaccin
realist
approach
would
let
chicken
inhal
aerosol
dri
powder
influenza
vaccin
formul
breath
passiv
administr
inde
passiv
inhal
dri
powder
influenza
vaccin
formul
feasibl
chicken
anim
partial
protect
indic
delay
time
death
reduc
viru
shed
henc
effici
influenza
immun
passiv
inhal
must
improv
pulmonari
vaccin
becom
feasibl
possibl
approach
could
increas
concentr
aerosol
vaccin
expos
anim
aerosol
powder
longer
period
time
includ
adjuv
vaccin
formul
effect
adjuv
cheap
readili
avail
potent
also
safe
adjuv
gener
recogn
safe
blp
blp
produc
hot
acid
treatment
ph
min
lactococcu
lacti
nonpathogen
foodgrad
gramposit
bacterium
blp
act
tolllik
ligand
shown
potent
immun
boost
properti
administ
togeth
vaccin
influenza
yersinia
pesti
malaria
pneumococc
diseas
besid
tolllik
receptor
ligand
natur
deriv
polysaccharid
exampl
adjuv
compris
insolubl
isoform
inulin
boost
vaccin
respons
mechan
still
fulli
character
pre
clinic
studi
advax
shown
enhanc
immun
respons
induc
wide
varieti
vaccin
includ
vaccin
hepat
b
sar
coronaviru
listeria
influenza
upon
parenter
administr
advax
shown
good
safeti
toler
record
anim
studi
clinic
trial
aim
current
studi
investig
whether
passiv
administr
dri
nonadjuv
adjuv
influenza
formul
potenti
complet
protect
chicken
lethal
hpaiv
challeng
initi
test
whether
blp
advax
could
coformul
influenza
vaccin
dri
powder
formul
suitabl
pulmonari
immun
b
adjuv
potenti
boost
system
mucos
immun
respons
influenza
c
passiv
administr
either
nonadjuv
adjuv
influenza
formul
would
protect
chicken
lethal
hpaiv
challeng
immun
reassort
viru
prepar
revers
genet
viru
apr
viru
use
nibsc
code
viru
cultur
embryon
chicken
egg
allanto
inocul
seed
viru
viru
purifi
inactiv
describ
previous
obtain
whole
inactiv
viru
vaccin
wiv
challeng
highli
pathogen
avian
influenza
viru
strain
clade
obtain
anim
health
veterinari
laboratori
agenc
weybridg
uk
use
activ
administr
ha
wiv
sfd
either
admix
adjuv
blp
mucosi
groningen
netherland
advax
vaxin
adelaid
australia
variou
ratio
activ
administr
dose
blp
advax
mg
sfd
powder
respect
wiv
mix
blp
weight
ratio
ha
blp
wivadvax
weight
ratio
ha
advax
likewis
passiv
administr
ha
sfd
either
mix
blp
advax
dose
correspond
amount
ha
adjuv
mg
sfd
powder
nonadjuv
adjuv
formul
sfd
use
inulin
kda
sensu
roosenda
netherland
stabil
inulin
use
stabil
influenza
vaccin
amorph
water
solubl
potenti
adjuv
effect
wherea
advax
delta
inulin
crystallin
insolubl
water
potent
adjuv
activ
brief
wv
solut
wiv
inulin
without
adjuv
pump
flowrat
mlmin
twofluid
nozzl
spraydryer
flawil
switzerland
atom
airflow
lh
use
spray
vaccin
prepar
vessel
liquid
nitrogen
frozen
vaccin
prepar
place
christ
epsilon
freez
dryer
precool
shelf
temperatur
pressur
mbar
shelf
temperatur
slowli
increas
within
time
period
h
next
h
temperatur
increas
pressur
lower
mbar
dri
vaccin
powder
collect
climat
box
rel
humid
store
airtight
condit
philip
transmiss
electron
microscop
use
make
transmiss
electron
microscopi
imag
sfd
powder
contain
wiv
ha
formul
without
adjuv
ie
blp
mg
sfd
powder
advax
mg
sfd
powder
reconstitut
steril
filter
water
liquid
reconstitut
sfd
formul
place
plain
carbon
grid
rins
water
sampl
stain
twice
wt
uranyl
acet
gatan
type
ultrascan
ccd
camera
magnif
use
take
imag
receptor
bind
activ
wiv
sfd
without
adjuv
assess
hemagglutin
assay
sfd
powder
reconstitut
phosphat
buffer
salin
pb
concentr
ha
prepar
ad
v
bottom
plate
contain
pb
entir
mixtur
twofold
serial
dilut
guinea
pig
red
blood
cell
suspens
ad
well
plate
allow
stand
undisturb
two
hour
room
temperatur
hemagglutin
titer
read
two
hour
express
log
highest
dilut
red
blood
cell
agglutin
could
seen
capac
blp
activ
via
tolllik
evalu
use
cell
invivogen
toulous
franc
cell
number
pattern
recognit
receptor
bound
agonist
lead
activ
thu
product
secret
alkalin
phosphatas
schemat
illustr
shown
fig
cell
maintain
dmem
high
glucos
gibco
life
technolog
bv
bleiswijk
netherland
fb
lonza
basel
switzerland
invivogen
toulous
franc
mm
lglutamin
passag
confluenc
reach
approxim
cell
ad
flat
bottom
plate
stimul
untreat
blp
liquid
reconstitut
sfd
powder
formul
ha
blp
formul
without
blp
incub
maintain
h
co
measur
alkalin
phosphatas
level
invivogen
toulous
franc
ad
cell
supernat
h
absorb
measur
nm
use
spectrophotomet
sfdwiv
prepar
imag
use
jeol
jsm
microscop
jeol
ltd
tokyo
japan
powder
place
doublesid
sticki
carbon
tape
metal
disc
particl
coat
approxim
nm
gold
use
balzer
sputter
devic
balzer
union
liechtenstein
magnif
use
captur
imag
geometr
particl
size
distribut
powder
measur
use
helo
compact
model
ka
laser
diffract
apparatu
sympatec
gmbh
clausthalzellerfeld
germani
dispers
powder
highli
effici
rodo
dispers
system
sympatec
gmbh
clausthalzellerfeld
germani
use
pressur
bar
aerodynam
particl
size
distribut
calcul
use
equat
describ
bhide
et
al
sixti
old
specificpathogen
free
chicken
white
leghorn
randomli
divid
group
anim
anim
immun
twice
ie
day
day
sfdwiv
formul
either
nonadjuv
adjuv
blp
advax
administ
anim
use
dri
powder
insuffl
penncenturi
inc
philadelphia
usa
custom
length
deliveri
tube
design
deliv
powder
directli
syrinx
use
three
puff
ml
air
use
aerosol
mg
powder
fill
insuffl
anim
sacrif
day
blood
sampl
taken
day
immun
day
two
week
immun
day
two
week
immun
day
sacrific
day
lung
lavag
collect
flush
lung
ml
pb
describ
holt
et
al
obtain
sera
lung
lavag
store
use
overview
immun
scheme
group
shown
fig
b
passiv
administr
nonadjuv
adjuv
wiv
formul
old
specificpathogen
free
chicken
randomli
divid
group
chicken
one
anim
die
unknown
caus
start
experi
group
place
custom
box
volum
ml
eppendorf
tube
fill
mg
sfd
powder
contain
mg
ha
wiv
without
adjuv
punctur
bottom
hypoderm
needl
lid
eppendorf
tube
fit
pressur
air
contain
bottom
conic
part
tube
insert
airtight
hole
drill
custom
box
dispers
powder
sfd
powder
aerosol
box
use
sever
puls
pressur
air
result
theoret
concentr
mg
ham
ha
dose
dispers
mg
inhal
box
volum
first
vaccin
anim
expos
aerosol
vaccin
min
everi
min
short
puls
medicin
oxygen
flow
rate
lmin
suppli
anoth
hole
box
second
vaccin
week
later
ie
day
exposur
time
min
short
puls
oxygen
flow
rate
lmin
everi
minut
base
respir
rate
chicken
lhkg
bodi
weight
exposur
time
would
result
maximum
theoret
dose
ha
per
anim
per
applic
eid
embryoinfecti
dose
titr
challeng
strain
stock
log
eid
ml
use
calcul
dilut
challeng
viru
chicken
lethal
dose
viru
log
eid
day
anim
challeng
lethal
dose
log
eid
viru
combin
intranasalintratrach
rout
liquid
suspens
ml
back
titrat
determin
tcid
tissu
cultur
infecti
dose
titr
tcid
ml
backtitr
challeng
viru
receiv
stabl
challeng
inocul
wherea
titr
origin
stock
thu
titr
eid
ml
correspond
tcid
ml
titr
tcid
ml
backtitr
therefor
correspond
least
eid
ml
sinc
chicken
lethal
dose
challeng
viru
log
eid
dose
ml
eid
ml
suffici
cld
kill
nonvaccin
anim
previou
studi
viru
batch
dilut
found
dose
kill
nonvaccin
control
group
anim
within
day
challeng
studi
challeng
anim
observ
clinic
sign
day
post
challeng
choanal
cloacal
swab
collect
viru
quantif
day
anim
sacrif
overview
immunizationchalleng
scheme
along
group
shown
fig
passiv
inhal
dri
formul
could
seen
video
file
supplementari
data
viru
titer
choanal
cloacal
swab
determin
per
method
describ
van
der
goot
et
al
challeng
viru
tenfold
serial
dilut
follow
rna
extract
standard
curv
consist
rna
serial
dilut
prepar
per
standard
curv
pcr
data
convert
equival
viru
titer
eqtcid
ml
serum
sampl
lung
wash
use
determin
igi
iga
antibodi
titer
determin
igi
titer
elisa
perform
previous
describ
except
secondari
antibodi
consist
goat
anti
chicken
igyhrp
southern
biotech
birmingham
usa
igi
titer
determin
log
reciproc
sampl
dilut
correspond
absorb
wavelength
nm
iga
titer
determin
lung
wash
use
commerci
avail
chicken
iga
elisa
kit
per
manufactur
instruct
abcam
cambridg
uk
hi
assay
perform
describ
previous
briefli
hemagglutin
unit
inactiv
viru
ad
twofold
dilut
sera
sampl
hi
titer
record
highest
serum
dilut
capabl
prevent
hemagglutin
hi
titer
present
log
scale
microneutr
titer
determin
previous
describ
briefli
twofold
serial
dilut
serum
sampl
prepar
tcid
viru
ad
well
well
plate
h
incub
mixtur
serum
viru
transfer
mdck
cell
atcc
germani
cultur
flat
bottom
plate
h
incub
supernat
discard
replac
episerfmedium
uml
penicillin
mgml
streptomycin
hepe
sodium
bicarbon
life
bv
bleiswijk
netherland
supplement
tpck
trypsin
sigmaadrich
netherland
h
incub
supernat
transfer
v
bottom
plate
microneutr
titer
calcul
find
highest
serum
dilut
capabl
prevent
hemagglutin
microneutr
titer
present
log
scale
mannwhitney
one
tail
test
use
compar
whether
differ
nonadjuv
adjuv
influenza
vaccin
formul
signific
level
signific
denot
p
p
p
respect
order
investig
potenti
blp
advax
mucos
adjuv
chicken
essenti
investig
whether
physic
biolog
properti
wiv
adjuv
remain
unalt
sfd
evalu
whether
admix
adjuv
wiv
sfd
influenc
physic
appear
wiv
blp
advax
particl
transmiss
electron
microscopi
analysi
perform
sampl
sfd
powder
sampl
reconstitut
prior
use
transmiss
electron
microscopi
pictur
show
wiv
blp
advax
particl
compar
morpholog
appear
sfd
fig
thu
neither
stress
encount
sfd
admix
adjuv
wiv
advers
effect
physic
appear
biolog
activ
wiv
need
preserv
addit
adjuv
sfd
order
investig
whether
receptor
bind
activ
ha
preserv
hemagglutin
assay
perform
differ
hemagglutin
titer
could
detect
either
addit
adjuv
sfd
thu
indic
detriment
effect
adjuv
sfd
biolog
activ
ha
fig
furthermor
effect
sfd
biolog
activ
blp
evalu
purpos
reconstitut
blpadjuv
sfd
wiv
formul
compar
unprocess
dispers
liquid
wiv
blp
capac
activ
use
cell
deriv
wiv
alon
found
poor
activ
reconstitut
blpadjuv
wiv
formul
activ
similar
extent
nativ
liquid
wivblp
dispers
thu
stress
encount
sfd
effect
biolog
activ
blp
activ
tolllik
receptor
fig
assess
whether
incorpor
blp
advax
sfd
formul
effect
physic
characterist
powder
particl
scan
electron
microscopi
use
analyz
physic
appear
sfd
formul
spheric
shape
intact
particl
interconnect
porou
structur
could
seen
nonadjuv
adjuv
wiv
formul
major
differ
could
observ
morpholog
sfd
particl
vari
dose
ha
addit
adjuv
repres
pictur
nonadjuv
blp
advax
adjuv
wiv
formul
ha
dose
per
mg
powder
shown
fig
c
upon
determin
geometr
particl
size
averag
particl
size
x
found
nonadjuv
adjuv
wiv
formul
fig
howev
inhal
aerodynam
particl
size
consid
suitabl
averag
aerodynam
particl
size
nonadjuv
well
adjuv
wiv
formul
calcul
accord
formula
describ
bhide
et
al
averag
aerodynam
particl
size
found
major
particl
x
size
fig
particl
size
rang
consid
suitabl
deposit
entir
respiratori
tract
chicken
overal
result
indic
sfd
produc
blp
advaxadjuv
wiv
particl
physic
biolog
characterist
make
suitabl
pulmonari
vaccin
activ
administr
tip
insuffl
place
directli
syrinx
chicken
three
puff
ml
air
use
dispers
powder
next
evalu
system
mucos
immun
respons
induc
chicken
activ
administr
serum
igi
hi
titer
measur
day
day
wherea
serum
mn
lung
igi
iga
titer
measur
day
day
nonadjuv
well
adjuv
wiv
formul
induc
consider
serum
igi
titer
advaxadjuv
wiv
formul
induc
significantli
higher
serum
igi
titer
correspond
nonadjuv
wiv
formul
fig
howev
major
differ
found
among
nonadjuv
blpadjuv
wiv
formul
except
correspond
ha
formul
fig
although
differ
statist
signific
major
howev
day
significantli
higher
titer
induc
blpadjuv
wiv
formul
nonadjuv
wiv
formul
ha
dose
differ
nonadjuv
blpadjuv
formul
signific
ha
dose
fig
advaxadjuv
wiv
formul
significantli
higher
titer
correspond
nonadjuv
wiv
formul
induc
ha
formul
fig
system
immun
respons
assess
determin
serum
hi
titer
found
first
vaccin
ie
day
none
vaccin
chicken
detect
hi
titer
fig
howev
second
vaccin
blpadjuv
wiv
formul
dose
ha
induc
trend
toward
higher
hi
titer
mean
hi
titer
log
log
respect
correspond
nonadjuv
wiv
formul
mean
hi
titer
log
respect
fig
though
ha
dose
differ
statist
signific
ha
dose
significantli
higher
titer
could
seen
blpadjuv
wiv
formul
correspond
nonadjuv
formul
also
compar
nonadjuv
wiv
formul
small
nonsignific
increas
hi
titer
seen
advaxadjuv
wiv
formul
lowest
ha
dose
log
fig
day
microneutr
titer
found
line
hi
titer
comparison
nonadjuv
wiv
formul
advax
blpadjuv
wiv
formul
dose
ha
induc
increas
microneutr
titer
five
eight
fold
respect
fig
major
differ
seen
ha
dose
mucos
immun
respons
assess
determin
iga
igi
titer
lung
lavag
obtain
two
week
second
immun
lung
igi
titer
found
consist
serum
igi
titer
second
immun
blpadjuv
wiv
formul
induc
significantli
higher
lung
igi
titer
respect
nonadjuv
wiv
formul
dose
ha
fig
addit
advaxadjuv
wiv
formul
induc
higher
lung
igi
titer
nonadjuv
wiv
formul
ha
dose
though
differ
signific
fig
though
nonadjuv
wiv
formul
found
induc
consider
lung
iga
titer
inclus
blp
advax
boost
immun
respons
fig
found
dose
ha
blpadjuv
wiv
formul
boost
lung
iga
titer
log
approxim
four
fold
comparison
correspond
nonadjuv
wiv
formul
log
fig
advaxadjuv
wiv
formul
dose
ha
lung
iga
titer
augment
three
five
fold
compar
correspond
nonadjuv
wiv
formul
fig
passiv
administr
might
suitabl
method
mass
vaccin
chicken
passiv
administr
chicken
place
custom
made
box
allow
inhal
aerosol
vaccin
powder
breath
use
two
applic
week
apart
next
evalu
system
immun
respons
induc
chicken
passiv
administr
aerosol
powder
serum
igi
titer
determin
day
day
wherea
microneutr
titer
determin
day
adjuv
blp
advax
result
significantli
higher
serum
igi
titer
day
increas
three
five
fold
could
seen
coadministr
blp
advax
wiv
fig
howev
second
vaccin
blp
advaxblp
adjuv
wiv
formul
significantli
higher
serum
igi
titer
log
nonadjuv
wiv
formul
log
fig
augment
serum
igi
titer
sixfold
blpadjuv
wiv
three
fold
advax
blpadjuv
wiv
fig
trend
hi
titer
agreement
serum
igi
titer
first
second
immun
first
immun
three
formul
ie
blp
advax
advaxblp
adjuv
wiv
formul
show
significantli
higher
hi
titer
mean
hi
titer
log
nonadjuv
wiv
formul
mean
hi
titer
log
fig
notabl
second
immun
blp
adjuv
advaxblpadjuv
wiv
formul
induc
significantli
higher
hi
titer
mean
hi
titer
log
nonadjuv
wiv
advax
adjuv
wiv
mean
hi
titer
log
addit
microneutr
titer
determin
second
immun
also
line
serum
igi
hi
titer
blp
advaxblp
adjuv
wiv
formul
induc
sixfold
higher
microneutr
titer
log
nonadjuv
wiv
formul
log
fig
assess
whether
passiv
administr
nonadjuv
adjuv
influenza
vaccin
formul
potenti
reduc
diminish
shed
challeng
viru
lethal
challeng
viru
shed
determin
choanal
cloacal
swab
previou
studi
found
nonvaccin
anim
shed
viru
succumb
infect
day
post
challeng
studi
similar
dose
viru
use
challeng
chicken
combin
intranasalintratrach
rout
viru
found
either
choanal
cloacal
swab
anim
immun
nonadjuv
blp
adjuv
advaxblp
adjuv
wiv
formul
tabl
two
anim
immun
advaxadjuv
wiv
formul
show
viru
choanal
swab
tabl
studi
demonstr
blp
advax
coformul
influenza
vaccin
dri
formul
suitabl
pulmonari
immun
chicken
upon
activ
administr
chicken
adjuv
blp
advax
shown
augment
system
mucos
immun
respons
remark
optim
setup
passiv
administr
chicken
either
nonadjuv
blp
advax
adjuv
wiv
formul
induc
robust
immun
respons
suffici
high
protect
chicken
lethal
viral
challeng
furthermor
blp
advaxblp
adjuvant
significantli
rais
level
antigenspecif
serum
antibodi
real
life
situat
passiv
inhal
would
perform
larg
room
portion
aerosol
vaccin
formul
would
also
end
food
water
howev
previou
studi
shown
ha
influenza
vaccin
undergo
conform
chang
acid
ph
thu
suscept
proteolyt
cleavag
acid
environ
consequ
littleno
neutral
antibodi
induc
acid
ph
treat
influenza
vaccin
therefor
specul
acid
environ
stomach
chicken
would
realli
add
lung
induc
mucos
immun
crystallin
natur
advax
peptidoglycan
surfac
blp
might
detriment
effect
influenza
vaccin
product
adjuv
dri
powder
formul
howev
inclus
blp
advax
togeth
wiv
formul
led
format
dri
powder
particl
compar
physic
biolog
characterist
nonadjuv
wiv
formul
moreov
physic
properti
adjuv
ie
size
shape
found
unalt
sfd
also
biolog
activ
blp
found
well
preserv
sfd
previou
studi
shown
administr
blp
advax
adjuv
influenza
vaccin
formul
via
respiratori
tract
result
substanti
augment
system
mucos
immun
respons
mice
studi
show
activ
administr
system
immun
respons
serum
igi
titer
one
immun
predominantli
enhanc
advax
wherea
two
immun
serum
igi
hi
titer
microneutr
titer
mainli
enhanc
blp
two
immun
nonadjuv
adjuv
wiv
formul
ha
dose
induc
averag
hi
titer
log
previous
found
requir
protect
lethal
dose
influenza
viru
respect
mucos
immun
respons
lung
igi
titer
mainli
enhanc
blp
wherea
lung
iga
titer
augment
blp
advax
though
blp
advax
found
enhanc
either
system
mucos
immun
respons
observ
discrep
might
due
dose
blp
advax
use
studi
although
dose
blp
advax
found
suffici
high
boost
system
mucos
immun
respons
mice
howev
dose
might
low
chicken
higher
bodi
weight
might
result
adjuv
dose
limit
factor
activ
administr
studi
activ
administr
studi
reveal
slight
significantli
higher
effect
blp
advax
adjuv
comparison
nonadjuv
wiv
formul
henc
passiv
administr
studi
rel
dose
blp
increas
doubl
ie
sfd
powder
keep
dose
advax
similar
sinc
advax
particl
consist
wt
sfd
powder
formul
enhanc
dose
advax
would
like
compromis
integr
powder
particl
moreov
pattern
advax
effect
one
blp
two
immun
could
also
determin
activ
administr
studi
therefor
one
group
passiv
administ
anim
inhal
advaxadjuv
wiv
first
immun
blpadjuv
wiv
second
immun
previou
studi
passiv
inhal
led
ineffici
deliveri
influenza
vaccin
powder
lung
chicken
thu
provid
partial
protect
henc
studi
aim
complet
protect
lethal
influenza
viral
challeng
achiev
enhanc
vaccin
powder
deliveri
lung
increas
vaccin
concentr
reduc
size
inhal
box
increas
exposur
time
use
adjuv
compar
previou
studi
optim
vaccin
concentr
exposur
time
result
increment
fold
theoret
vaccin
dose
studi
haanim
previou
studi
haanim
use
optim
setup
passiv
inhal
nonadjuv
adjuv
wiv
formul
protect
chicken
clinic
sign
hpaiv
challeng
also
almost
complet
prevent
challeng
viru
shed
result
signific
improv
previou
studi
chicken
show
partial
protect
challeng
viru
shed
even
three
immun
though
immunolog
mechan
govern
complet
protect
chicken
passiv
administr
nonadjuv
adjuv
wiv
formul
still
need
investig
shed
data
indic
mucos
immun
respons
high
enough
prevent
product
substanti
amount
viru
addit
mucos
immun
respons
import
class
immun
respons
elicit
system
time
point
blp
advaxblp
adjuv
wiv
formul
found
induc
higher
system
immun
respons
nonadjuv
advaxadjuv
wiv
prepar
addit
found
either
two
adjuv
ie
advax
blp
would
appropri
first
immun
howev
second
immun
blp
vital
although
adjuv
wiv
formul
elicit
significantli
higher
immun
respons
nonadjuv
wiv
formul
fact
even
nonadjuv
wiv
formul
provid
complet
protect
suggest
use
adjuv
critic
protect
via
passiv
inhal
might
add
dosespar
influenza
vaccin
futur
passiv
inhal
studi
conclus
result
show
vaccin
passiv
inhal
dri
influenza
vaccin
powder
suitabl
induc
protect
immun
chicken
highli
pathogen
avian
influenza
viru
potenti
complet
protect
chicken
morbid
mortal
prevent
viru
spread
also
seem
feasibl
option
mass
vaccin
chicken
challeng
remain
translat
passiv
inhal
vaccin
box
realworld
field
set
np
affili
vaxin
pti
ltd
commerci
interest
advax
adjuv
author
declar
conflict
interest
research
fund
dutch
ministri
econom
affair
